To test whether ANGPTL2-containing SEVs from ECs enhanced B-ALL progression, we generated Cdh5-Cre;Angptl2fl/fl mice to specifically delete Angptl2 in ECs and transplanted B-ALL cells into these recipient mice. This evidence concerns the gene CDH5 and precursor B-cell acute lymphoblastic leukemia.